您的位置: 首页 > 农业专利 > 详情页

Pyrrolobenzodiazepines used to treat proliferative diseases
专利权人:
MedImmune Limited;Seattle Genetics, Inc.
发明人:
Howard, Philip Wilson,Masterson, Luke,Tiberghien, Arnaud,Jeffrey, Scott,Burke, Patrick,Senter, Peter
申请号:
ES14173641
公开号:
ES2623057T3
申请日:
2011.04.15
申请国别(地区):
ES
年份:
2017
代理人:
摘要:
A compound with the formula I: ** Formula ** in which: R2 is of the formula II: ** Formula ** in which A is a C5-7 aryl group, X is selected from the group consisting of: OH, SH, CO2H, COH, N>; = C>; = O, NHNH2, CONHNH2, ** Formula ** and NHRN, wherein RN is selected from the group comprising H and C1-4 alkyl and: (i) Q1 is a single link and Q2 is selected from a single link and -Z- (CH2) n-, where Z is selected from a single link, O, S and NH and is 1 to 3; or (ii) Q1 is -CH>; = CH- and Q2 is a single link; R12 is selected from: (iia) saturated aliphatic C1-5 alkyl; (iib) saturated C3-6 cycloalkyl; (iic) ** Formula ** in which each of R21, R22 and R23 is independently selected from H, saturated C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl and cyclopropyl, where the total number of atoms of carbon in the R12 group is not greater than 5; (iid) ** Formula ** wherein one of R25a and R25b is H and the other is selected from: phenyl, phenyl which is optionally substituted with a group selected from halo, methyl, methoxy, pyridyl and thiophenyl; and (iie) ** Formula ** wherein R24 is selected from H, saturated C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl; cyclopropyl; phenyl, phenyl which is optionally substituted with a group selected from halo, methyl, methoxy, pyridyl and thiophenyl; R6 and R9 are independently selected from H, R, OH, OR, SH, SR, NH2, NHR, NRR ', nitro, Me3Sn and halo; R7 is selected from H, R, OH, OR, SH, SR, NH2, NHR, NHRR ', nitro, Me3Sn and halo; where R and R 'are independently selected from optionally substituted C1-12 alkyl, C3-20 heterocyclyl and C5-20 aryl groups; either: (a) R10 is H, and R11 is OH, ORA, where RA is C1-4 alkyl; (b) R10 and R11 form a double nitrogen-carbon bond between the nitrogen and carbon atoms to which they are attached; or (c) R10 is H and R11 is SOzM, where z is 2 or 3 and M is a pharmaceutically acceptable monovalent cation; R '' is a C3-12 alkylene group, whose chain may be interrupted by one or more heteroatoms and / or a
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充